OPTIM-PARK 2

  • Research type

    Research Study

  • Full title

    OPTIM-PARK II - A new intervention for optimisation of community resources and systems of support to enhance the process of living with Parkinson’s Disease: a feasibility trial

  • IRAS ID

    308776

  • Contact name

    mc PORTILLO

  • Contact email

    M.C.Portillo-Vega@soton.ac.uk

  • Sponsor organisation

    University of Southampton

  • Clinicaltrials.gov Identifier

    NCT05583994

  • Duration of Study in the UK

    0 years, 8 months, 0 days

  • Research summary

    This project aims to test if a new intervention designed for people living with Parkinson’s Disease (PD) can be used in practice.
    Many people with PD contact health services to receive support and care, meeting with professionals from different services and organisations. At the moment there is not a single point of contact and people have to search what is available for them and where to go.
    We have designed with the help of patients, carers and professionals a new intervention, called OPTIM-PARK. It will bring all collaborations of care together to support people living with PD. In the first iterative phase (Months 1-2) of the project we will pilot and make any changes needed to the recruitment and intervention procedures as well as informing stakeholders in the Wessex area about the intervention to support recruitment. These stakeholders will be asked to identify and inform people with Parkinson’s about the study The second phase will involve people with PD and their families and signpost them to personalised resources (for 4 months).
    We will test the intervention in 2 geographical areas (Salisbury and Portsmouth) within Wessex. Two clinics in each area will participate in the delivery of the intervention (usual care vs intervention).

    All patient participants who agree to take part will be assessed at point of entry to the study (baseline) and three months later (follow up). Assessments will include information about living with Parkinson’s and other instruments.

    60 people with Parkinson’s and family carers will be recruited and allocated to the intervention group or to the control group, receiving usual care. We anticipate that approximately 30 people with Parkinson’s and their carers will receive the intervention.

    At the end of the study lay summary information about the findings of the study will be shared with study participants.

  • REC name

    West Midlands - Solihull Research Ethics Committee

  • REC reference

    22/WM/0131

  • Date of REC Opinion

    11 Jul 2022

  • REC opinion

    Further Information Favourable Opinion